Impact of Anti-cytomegalovirus (Valganciclovir) Treatment in the Management of Relapsing Ulcerative Colitis (UC) Requiring Vedolizumab Therapy: a Randomized Clinical Trial Comparing a Strategy With or Without Antiviral Therapy.
Condition: Ulcerative Colitis, Unspecified Intervention: Drug: Valganciclovir Sponsors: Centre Hospitalier Universitaire de Saint Etienne; Ministry of Health, France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 22, 2019 Category: Research Source Type: clinical trials
The efficacy of a cyclin dependent kinase 9 (CDK9) inhibitor, FIT039, on verruca vulgaris: study protocol for a randomized controlled trial
This study is the first to assess the efficacy of FIT039 and will contribute to the development of antiviral agents that can cure refractory common warts in immunocompromised patients.Trial registrationUMIN Clinical Trials,UMIN000029695. Registered on 1 November 2017. (Source: Trials)
Source: Trials - August 8, 2019 Category: Research Source Type: clinical trials
Safety and Immunotherapeutic Activity of Cemiplimab in Participants With HBV on Suppressive Antiviral Therapy
Condition: Hepatitis B Virus Intervention: Biological: Cemiplimab Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 6, 2019 Category: Research Source Type: clinical trials
